MedPath
FDA Approval

Dobutamine

January 2, 2023

HUMAN PRESCRIPTION DRUG LABEL

Dobutamine(12.5 mg in 1 mL)

Registrants (1)

Hainan Poly Pharm. Co., Ltd.

654561638

Manufacturing Establishments (1)

Hainan Poly Pharm. Co., Ltd.

Hainan Poly Pharm. Co., Ltd.

Hainan Poly Pharm. Co., Ltd.

654561638

Products (2)

Dobutamine

14335-171

ANDA216131

ANDA (C73584)

INTRAVENOUS

January 2, 2023

SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACTQuantity: 0.2 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: 0WR771DJXVClass: ACTIMQuantity: 12.5 mg in 1 mL

Dobutamine

14335-172

ANDA216131

ANDA (C73584)

INTRAVENOUS

January 2, 2023

SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACTQuantity: 0.2 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: 0WR771DJXVClass: ACTIMQuantity: 12.5 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath